UNITED THERAPEUTICS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 233.8 USD | -0.89% |
|
-1.71% | +6.35% |
| 23/04 | United Therapeutics Insider Sold Shares Worth $1,704,174, According to a Recent SEC Filing | MT |
| 23/04 | United Therapeutics Q1 Results Could Fall Short of Market Expectations, Oppenheimer Says | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 239.40 | 256.94 | 248.24 |
| Spread/Res. | -2.32% | -8.99% | -5.80% |
| Spread/Supp. | +2.45% | +10.96% | +12.80% |
| Support | 228.26 | 210.76 | 207.32 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- UTHR Stock
- Charts United Therapeutics Corporation
